{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_001130802.3:c.1081G>A",
          "cDNA Change": {
            "transcript": "NM_001130802.3",
            "ref": "G",
            "alt": "A",
            "position": "1081"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "361"
          },
          "Description in input context": "c.1081G>A (p.G361R)"
        },
        {
          "HGVS": "NM_001130802.3:c.1081G>T",
          "cDNA Change": {
            "transcript": "NM_001130802.3",
            "ref": "G",
            "alt": "T",
            "position": "1081"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "V",
            "position": "361"
          },
          "Description in input context": "c.1081G>T (p.G361V)"
        },
        {
          "HGVS": "NM_001130802.3:c.1081G>C",
          "cDNA Change": {
            "transcript": "NM_001130802.3",
            "ref": "G",
            "alt": "C",
            "position": "1081"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "361"
          },
          "Description in input context": "c.1081G>C (p.G361A)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005315"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with PARK2 variants for ubiquitination analysis."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130802.3:c.1081G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced ubiquitination activity by 40% compared to wild-type."
        },
        {
          "Variant": "NM_001130802.3:c.1081G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced ubiquitination activity by 35% compared to wild-type."
        },
        {
          "Variant": "NM_001130802.3:c.1081G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced ubiquitination activity by 30% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination activity ≥ 70% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination activity < 70% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were used to study PARK2-Parkin interaction."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130802.3:c.1081G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced PARK2-Parkin interaction by 25% compared to wild-type."
        },
        {
          "Variant": "NM_001130802.3:c.1081G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced PARK2-Parkin interaction by 20% compared to wild-type."
        },
        {
          "Variant": "NM_001130802.3:c.1081G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced PARK2-Parkin interaction by 15% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "PARK2-Parkin interaction ≥ 60% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "PARK2-Parkin interaction < 60% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with PARK2 variants to assess cell viability."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130802.3:c.1081G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability reduced by 20% compared to wild-type."
        },
        {
          "Variant": "NM_001130802.3:c.1081G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability reduced by 15% compared to wild-type."
        },
        {
          "Variant": "NM_001130802.3:c.1081G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability reduced by 10% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability ≥ 85% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability < 85% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}